Status:

COMPLETED

CR: Developing an Intervention to Improve Acceptance of Referral in HF

Lead Sponsor:

University of Leicester

Collaborating Sponsors:

British Heart Foundation

Conditions:

Heart Failure

Frailty

Eligibility:

All Genders

18+ years

Brief Summary

Background: There are proven benefits to people with chronic heart failure (CHF) participating in a cardiac rehabilitation (CR) programme, however uptake remains disappointingly low. Admission to hosp...

Detailed Description

Trial Design: Mixed method approach to development of an intervention: observational cohort study, semi-structured interviews, focus groups, staff survey, theory informed intervention development usin...

Eligibility Criteria

Inclusion

  • Observational study:
  • Clinical diagnosis of chronic heart failure confirmed by cardiac imaging.
  • Current admission for which the primary reason was decompensated heart failure requiring IV diuretics
  • Referred to the acute trusts heart failure nursing service
  • Able to give informed consent
  • Able to communicate in spoken English

Exclusion

  • Contraindications to participating in cardiac rehabilitation as detailed in ESC consensus statement e.g. uncontrolled hypertension severe aortic stenosis, unstable angina
  • Moderate to severe cognitive impairment
  • Patients with severe dependence prior to index admission (inability to carry out ADL)
  • Admitted from a nursing home
  • Resident 'out of area'
  • Significant co-morbidities that would limit participation in a cardiac rehabilitation programme e.g. neurodegenerative conditions
  • Previous recruitment onto this study
  • Semi-structured interviews: Purposive sampling
  • Inclusion criteria:
  • Patients with chronic heart failure who fulfil the criteria for referral to the cardiac rehabilitation service will be eligible to participate in the interviews if they are:
  • Age 18 years or over
  • Have a clinical diagnosis of CHF confirmed by cardiac imaging.
  • Referred to the acute trusts heart failure nursing service and/or cardiac rehabilitation team
  • Able to give informed consent
  • Able to communicate in spoken English
  • Exclusion criteria:
  • Contraindications to participating in cardiac rehabilitation as detailed in ESC consensus statement (See Appendix D) e.g. uncontrolled hypertension, severe aortic stenosis, unstable angina
  • Moderate to severe cognitive impairment
  • Nursing home resident
  • Significant co-morbidities that would limit participation in a cardiac rehabilitation programme e.g. neurodegenerative conditions
  • Previous recruitment onto this study
  • Focus groups: convenience sampling
  • Inclusion criteria:
  • Staff from study site who are involved in the provision of cardiac rehabilitation to people with heart failure will be eligible to participate in the focus group.
  • Survey: convenience sampling
  • Inclusion criteria:
  • Health care professionals who refer to or deliver cardiac rehabilitation.

Key Trial Info

Start Date :

February 5 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2022

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT04276675

Start Date

February 5 2020

End Date

November 1 2022

Last Update

September 15 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Glenfield Hospital

Leicester, Leicestershire, United Kingdom, LE3 9QP